XORTX Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -40 | -29 | -28 | -25 |
EBITDA | -916 | -613 | -862 | -937 |
EBIT | -957 | -642 | -889 | -963 |
Net Income | -823 | -642 | -717 | -698 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -979 | -620 | -815 | -647 |
Cash | 1,185 | 1,661 | 1,063 | 1,895 |
Basic Shares | 262 | 194 | 151 | 149 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -156 | -160 | -141 | -75 |
EBITDA | -4,392 | -4,378 | -6,468 | -9,410 |
EBIT | -4,549 | -4,539 | -6,657 | -9,485 |
Net Income | -3,711 | -4,539 | -2,859 | -6,988 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,868 | -5,039 | -6,629 | -9,009 |
Cash | 1,185 | 3,557 | 3,447 | 10,434 |
Basic Shares | 189 | 115 | 79 | 59 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.45 |
2025-09-30 | -$0.13 |
2025-06-30 | -$0.19 |
2025-03-31 | $0.04 |
